1. Academic Validation
  2. Small Molecule Inhibitor of ATPase Activity of HSP70 as a Broad-Spectrum Inhibitor against Flavivirus Infections

Small Molecule Inhibitor of ATPase Activity of HSP70 as a Broad-Spectrum Inhibitor against Flavivirus Infections

  • ACS Infect Dis. 2020 May 8;6(5):832-843. doi: 10.1021/acsinfecdis.9b00376.
Jingjing Yang 1 Yongfen Xu 2 Yunzheng Yan 1 Wei Li 1 Lei Zhao 1 Qingsong Dai 1 Yuexiang Li 1 Song Li 1 Jin Zhong 2 Ruiyuan Cao 1 Wu Zhong 1
Affiliations

Affiliations

  • 1 National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
  • 2 CAS Key Laboratory of Molecular Virology and Immunology, Unit of Viral Hepatitis, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Abstract

Flaviviruses including Zika virus, Dengue virus, Japanese Encephalitis virus, and Yellow Fever virus cause heavy burdens to public health around the world. No specific Antiviral drug is available in the clinic against these Flavivirus infections. Heat-shock protein 70 (HSP70) has recently been proven to be a promising Antiviral target against Zika virus and Dengue virus. Here, we report that Apoptozole, a small molecule inhibitor of ATPase activity of HSP70, has broad-spectrum anti-flavivirus potential. The mode of action analysis revealed that Apoptozole acted at the post-entry step. Transcriptome analysis revealed that genes related to Cholesterol metabolism, fatty acid synthesis, and innate immunity were differentially expressed after treatment with Apoptozole. In vivo data suggested Apoptozole exerted protection effects against Zika virus (ZIKV) Infection in a mouse model by enhancing the innate immune response, which suggested a novel anti-ZIKV mechanism of HSP70 inhibitors.

Keywords

Apoptozole; Zika virus; antiviral; flavivirus; innate immunity.

Figures
Products